{
    "name": "fluorometholone",
    "comment": "Rx",
    "other_names": [
        "Flarex",
        "FML",
        "FML Forte"
    ],
    "classes": [
        "Antivirals",
        "Ophthalmic",
        "Corticosteroids",
        "Ophthalmic"
    ],
    "source": "https://reference.medscape.com/drug/flarex-fml-fluorometholone-343624",
    "pregnancy": {
        "common": [
            "There are no adequate and well controlled studies in pregnant women, and it is not known whether this drug can cause fetal harm when administered to a pregnant woman; the drug should only be used during pregnancy only if potential benefit justifies the potential risk to the fetus"
        ],
        "specific": [
            {
                "type": "Animal data",
                "description": [
                    "Fluorometholone has been shown to be embryocidal and teratogenic in rabbits when administered at low multiples of the human ocular dose; the drug was applied ocularly to rabbits daily on days 6-18 of gestation, and dose-related fetal loss, and fetal abnormalities including cleft palate, deformed rib cage, anomalous limbs and neural abnormalities such as encephalocele, craniorachischisis, and spina bifida were observed"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "Systemically administered corticosteroids appear in human milk and could suppress growth, interfere with endogenous corticosteroid production, or cause other untoward effects",
            "It is not known whether topical administration of corticosteroids could result in sufficient systemic absorption to produce detectable quantities in human milk; because many drugs are excreted in human milk, caution should be exercised when the drug is administered to a nursing woman"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity to any component of the formulation",
                "Herpes simplex keratitis, ocular fungal or mycobacterial infections",
                "Acute purulent untreated infections",
                "Vaccinia, varicella, and most other viral diseases of cornea and conjunctiva",
                "Cataracts, glaucoma, ophthalmic infection"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Monitor closely with diabetes mellitus",
                "Prolonged use of corticosteroids may increase IOP in susceptible individuals, resulting in glaucoma with damage to the optic nerve, defects in visual acuity and fields of vision, and in posterior subcapsular cataract formation; consider checking intraocular pressure frequently",
                "Topical ophthalmic corticosteroids may slow corneal wound healing; in those diseases causing thinning of the cornea or sclera, perforation has been known to occur with chronic use of topical steroids",
                "Fungal infections of cornea are particularly prone to develop coincidentally with long-term local steroid application; fungus invasion must be considered in any persistent corneal ulceration where a steroid has been used or is in use",
                "May aid in establishment of secondary ocular infections from pathogens due to suppression of host response",
                "Acute purulent infections of the eye may be masked or exacerbated by presence of steroid medication",
                "May mask infection or enhance existing infection",
                "May exacerbate severity of viral infections; use caution in patients with history of herpes simplex; use great caution",
                "Contact lenses should be removed during instillation of fluorometholone acetate ophthalmic suspension but may be reinserted 15 minutes after instillation",
                "Patients should be advised that their vision may be temporarily blurred following dosing with fluorometholone acetate ophthalmic suspension; care should be exercised in operating machinery or driving a motor vehicle",
                "Do not touch dropper tip to any surface, as this may contaminate the suspension; the preservative in this product 0.1%, benzalkonium chloride, may be absorbed by soft contact lenses; contact lenses should be removed during instillation of the drug but may be reinserted 15 minutes after instillation",
                "Patients should be advised that their vision may be temporarily blurred following dosing with this drug; care should be exercised in operating machinery or driving a motor vehicle",
                "If these products are used for 10 days or longer, intraocular pressure (IOP) should be routinely monitored even though it may be difficult in children and uncooperative patients"
            ],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Glaucoma",
            "percent": null
        },
        {
            "name": "Cataract",
            "percent": null
        },
        {
            "name": "Potentiate super infection",
            "percent": null
        },
        {
            "name": "Slow wound healing",
            "percent": null
        },
        {
            "name": "Hypercorticoidism",
            "percent": null
        },
        {
            "name": "rare",
            "percent": null
        },
        {
            "name": "Allergic reactions",
            "percent": null
        },
        {
            "name": "Foreign body sensation",
            "percent": null
        },
        {
            "name": "Erythema of eyelid",
            "percent": null
        },
        {
            "name": "Eyelid edema",
            "percent": null
        },
        {
            "name": "eye swelling",
            "percent": null
        },
        {
            "name": "Eye discharge",
            "percent": null
        },
        {
            "name": "Eye pain",
            "percent": null
        },
        {
            "name": "Eye pruritus",
            "percent": null
        },
        {
            "name": "Lacrimation increased",
            "percent": null
        },
        {
            "name": "Rash",
            "percent": null
        },
        {
            "name": "Taste perversion",
            "percent": null
        },
        {
            "name": "Visual disturbance",
            "percent": null
        },
        {
            "name": "blurry vision",
            "percent": null
        },
        {
            "name": "Visual field defect",
            "percent": null
        },
        {
            "name": "Dysgeusia",
            "percent": null
        },
        {
            "name": "Cushing",
            "percent": null
        },
        {
            "name": "s syndrome",
            "percent": null
        },
        {
            "name": "after very frequent use of topical ophthalmic corticosteroids",
            "percent": null
        },
        {
            "name": "Adrenal suppression",
            "percent": null
        },
        {
            "name": "after very frequent use of topical ophthalmic corticosteroids",
            "percent": null
        }
    ]
}